Verrica Pharmaceuticals News

Verrica Pharmaceuticals Analyst Ratings

BenzingaMay 16 11:40 ET

Needham Reiterates Buy on Verrica Pharmaceuticals, Maintains $16 Price Target

BenzingaMay 16 11:41 ET

Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT) and Verrica Pharmaceuticals (VRCA)

TipRanksMay 16 09:20 ET

Needham Adjusts Price Target on Verrica Pharmaceuticals to $16 From $8, Keeps Buy Rating

MT NewswiresMay 14 08:50 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaMay 14 05:40 ET

Strong Buy Rating for Verrica Pharmaceuticals as Ycanth Launch Exceeds Expectations

TipRanksMay 13 10:25 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaApr 10 06:57 ET

RBC Capital Remains a Buy on Verrica Pharmaceuticals (VRCA)

TipRanksMar 1 07:28 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaMar 1 07:05 ET

Verrica Pharmaceuticals Outperforms With YCANTH Sales, Promising Outlook Spurs Buy Rating

TipRanksMar 1 06:28 ET

Buy Rating Affirmed for Verrica Pharmaceuticals Amidst Promising Ycanth Launch and Market Acceptance

TipRanksFeb 29 11:45 ET

Jefferies Reiterates Buy on Verrica Pharmaceuticals, Maintains $10 Price Target

BenzingaDec 15, 2023 13:37 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaDec 15, 2023 13:34 ET

Promising Outlook for Verrica Pharmaceuticals: Factors Leading to Livnat's Buy Rating

TipRanksNov 20, 2023 06:27 ET

RBC Capital Remains a Buy on Verrica Pharmaceuticals (VRCA)

TipRanksNov 10, 2023 20:48 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaNov 10, 2023 04:49 ET

Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and Verrica Pharmaceuticals (VRCA)

TipRanksNov 9, 2023 15:11 ET

HC Wainwright & Co. Reiterates Buy on Verrica Pharmaceuticals, Maintains $12 Price Target

BenzingaOct 12, 2023 06:37 ET

Verrica Pharmaceuticals Analyst Ratings

BenzingaOct 12, 2023 06:35 ET

Verrica Pharmaceuticals to Skyrocket: Oren Livnat Recommends a Buy Rating Based on Promising YCANTH Prospects

TipRanksOct 12, 2023 06:26 ET